Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model

PLoS One. 2014 Dec 12;9(12):e114670. doi: 10.1371/journal.pone.0114670. eCollection 2014.

Abstract

Liver damage caused by radiotherapy is associated with a high mortality rate, but no established treatment exists. Adipose-derived mesenchymal stem cells (ADSCs) are capable of migration to injured tissue sites, where they aid in the repair of the damage. Hepatocyte growth factor (HGF) is critical for damage repair due to its anti-apoptotic, anti-fibrotic and cell regeneration-promoting effects. This study was performed to investigate the therapeutic effects of HGF-overexpressing ADSCs on radiation-induced liver damage (RILD). ADSCs were infected with a lentivirus encoding HGF and HGF-shRNA. Sprague-Dawley (SD) rats received 60Gy of irradiation to induce liver injury and were immediately given either saline, ADSCs, ADSCs + HGF or ADSCs + shHGF. Two days after irradiation, a significant reduction in apoptosis was observed in the HGF-overexpressing ADSC group compared with the RILD group, as assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Scanning electron microscopy showed chromatin condensation after irradiation, which was ameliorated in the group that received ADSCs and was reversed in the group that received HGF-overexpressing ADSCs. HGF-overexpressing ADSCs ameliorated radiation- induced liver fibrosis through down regulation of α-SMA and fibronectin. Hepatocyte regeneration was significantly improved in rats treated with ADSCs compared with rats from the RILD group), as assessed by Ki-67 immunohistochemistry. Rats that received HGF-overexpressing ADSCs showed an even greater level of hepatocyte regeneration. HGF-overexpressing ADSCs completely blocked the radiation-induced increase in the enzymes ALT and AST. The effect of mitigating RILD was compromised in the ADSC + shHGF group compared with the ADSC group. Altogether, these results suggest that HGF-overexpressing ADSCs can significantly improve RILD in a rat model, which may serve as a valuable therapeutic alternative.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / cytology*
  • Animals
  • Apoptosis
  • Cell Movement
  • Disease Models, Animal
  • Fibrosis
  • Hepatocyte Growth Factor / genetics*
  • Hepatocytes / pathology
  • Humans
  • Liver / pathology
  • Liver / physiopathology
  • Liver / radiation effects
  • Liver Regeneration
  • Male
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / metabolism
  • Radiation Injuries, Experimental / genetics*
  • Radiation Injuries, Experimental / pathology
  • Radiation Injuries, Experimental / physiopathology
  • Radiation Injuries, Experimental / therapy*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Hepatocyte Growth Factor

Grants and funding

This work was supported by The National Key Technology Support Program (No. 2012BAI38B03), the National Natural Science Foundation of China (No. 81270643 and No. 81470343), and a Seeding Grant for Medicine and Engineering Sciences of Peking University (No. 2141000008). This work was also supported in part by the Beijing Natural Science Foundation (No. 7132194) and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120001110026). All these funds were received by Xiaohui Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.